Semaglutide is sold in Canada under several brand names — Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management. Compounded versions are also available through some telehealth providers. This guide compares every option on price, insurance coverage, clinical effectiveness and side effects so you can decide which is best for your situation.
Generic semaglutide arrived in Canada in May 2026, after Novo Nordisk's exclusivity on the molecule lapsed on January 4, 2026. It is the same semaglutide as Ozempic at roughly a third of the price, and it reshapes every cost comparison in this guide. See our generic semaglutide in Canada page for the full picture.
Generic semaglutide is now the cheapest reliable option in Canada. Apotex's Apo-Semaglutide and Dr. Reddy's generic launched in Canadian pharmacies in May 2026 at roughly $88/month at Costco and $100–$120 at most chain pharmacies — about a third the price of brand-name Ozempic. Telehealth providers Felix and Hims both list it at $149/month. → Read the full guide to generic semaglutide in Canada.
What Is Semaglutide and Why Canadians Are Paying Attention
Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk. It mimics the hormone glucagon-like peptide-1, which slows gastric emptying, increases insulin release in response to meals and signals fullness to the brain [1]. The same molecule is marketed in three different products at different doses for different indications.
Canadian interest has climbed steadily since Ozempic launched in 2018. Health Canada’s approval of Wegovy for chronic weight management in 2022, followed by the 2023 SELECT trial showing a 20% reduction in major adverse cardiovascular events [2], accelerated prescribing in both diabetes and obesity populations. Supply shortages through 2023–2024 have eased, and all three branded products are broadly available as of April 2026.
Every Semaglutide Product Available in Canada
Four semaglutide options are accessible to Canadians in 2026: three Health Canada-approved brand products plus compounded semaglutide from licensed compounding pharmacies. Each has a different indication, dose range and price.
| Product | Form | Dose Range | Approved For | Manufacturer | DIN |
|---|---|---|---|---|---|
| Ozempic | Once-weekly injection | 0.25–2.0 mg | Type 2 diabetes | Novo Nordisk | 02471469 / 02471477 / 02471485 |
| Wegovy | Once-weekly injection | 0.25–2.4 mg | Weight management (BMI 30+ or 27+ with comorbidity) | Novo Nordisk | 02528797 |
| Rybelsus | Daily oral tablet | 3, 7, 14 mg | Type 2 diabetes | Novo Nordisk | 02495910 / 02495929 / 02495937 |
| Compounded semaglutide | Vial + syringe | Pharmacy-set | Not Health Canada-approved — off-label via compounding pharmacies | Various licensed compounding pharmacies | N/A |
Ozempic: The Most Established Option
Ozempic arrived in Canada in 2018 and has the widest prescribing base of any semaglutide product. It is approved for type 2 diabetes, and many Canadians use it off-label for weight management when Wegovy is not covered.
Strengths:
- Best insurance coverage pathway — most provincial formularies cover Ozempic for eligible diabetes patients
- Long-term safety data from the SUSTAIN clinical program [3]
- Cardiovascular benefit shown in SUSTAIN 6
- Flexible dose range (0.25 mg up to 2.0 mg weekly)
Limitations:
- Not Health Canada-approved for weight management
- Maximum 2.0 mg dose is lower than Wegovy’s 2.4 mg
- Off-label weight-loss prescribing can trigger insurance denials
See our full Ozempic guide for dosing schedules and cost breakdowns.
Wegovy: The Only Option Approved for Weight Management
Wegovy received Health Canada approval in 2022 for chronic weight management in adults with BMI ≥ 30, or ≥ 27 with at least one weight-related comorbidity. It is the same semaglutide molecule as Ozempic, just titrated to a higher maximum dose of 2.4 mg weekly.
Strengths:
- Only semaglutide product Health Canada-approved for weight management
- Highest dose (2.4 mg) delivers the strongest average weight loss — about 15% body weight over 68 weeks in STEP 1 [4]
- SELECT trial demonstrated 20% reduction in major adverse cardiovascular events [2]
- Five-step titration schedule helps manage GI side effects
Limitations:
- Insurance coverage for weight management is inconsistent across provinces and private plans
- Higher dose means higher rates of nausea, vomiting and diarrhea during titration
- Out-of-pocket cost is roughly $380–$500 per month [5]
Read our Wegovy guide for titration tips and coverage advice.
Rybelsus: The Oral Alternative
Rybelsus is semaglutide in pill form, taken once daily on an empty stomach with no more than 120 mL of water. It was approved by Health Canada in 2020 for type 2 diabetes.
Strengths:
- No injections required
- Solid A1C reduction data from the PIONEER trial program [6]
- Covered by many private and provincial plans for diabetes
- Lower monthly cost than Ozempic or Wegovy
Limitations:
- Strict fasting and water instructions — absorption drops sharply if taken improperly
- Less weight loss than injectable semaglutide in head-to-head data
- Not approved for weight management
See our Rybelsus guide for dosing instructions and coverage details.
Compounded Semaglutide: Cheaper, but With Caveats
Licensed Canadian compounding pharmacies can prepare semaglutide from approved active pharmaceutical ingredient under a prescription. Compounded versions are not Health Canada-approved products and do not go through the same post-market surveillance as Novo Nordisk’s branded semaglutide. Some telehealth providers offer compounded semaglutide at prices below brand options.
Generic semaglutide (Apo-Semaglutide and Dr. Reddy's) arrived in Canadian pharmacies in May 2026, and at roughly $88 per month at Costco the cost case for compounded semaglutide has effectively collapsed.
Cost and Insurance Coverage Across Canada
Retail pricing for semaglutide in Canada is remarkably consistent across major pharmacy chains. Online telehealth providers sometimes offer bundled prescription-and-medication pricing below retail. The table below reflects typical 2026 pharmacy pricing for Canadians without insurance.
| Product (Dose) | Monthly Cost (No Insurance) | With Private Insurance | Annual Cost (No Insurance) |
|---|---|---|---|
| Ozempic (1.0 mg/week) | $250–$325 | $30–$80 copay | $3,000–$3,900 |
| Ozempic (2.0 mg/week) | $325–$375 | $50–$100 copay | $3,900–$4,500 |
| Wegovy (2.4 mg/week) | $380–$500 | $50–$120 copay | $4,560–$6,000 |
| Rybelsus (14 mg/day) | $220–$280 | $30–$70 copay | $2,640–$3,360 |
| Compounded semaglutide | $200–$350 | Not typically covered | $2,400–$4,200 |
For a deeper pricing breakdown see /semaglutide/cost/, /ozempic/cost/, /wegovy/cost/ and /rybelsus/cost/.
Provincial Drug Plan Coverage
Coverage for GLP-1 medications varies widely by province. Ozempic is the most consistently covered product (for diabetes) across provincial formularies. Wegovy coverage for weight management remains limited and typically requires prior authorization.
| Product | Typical Coverage | Special Authorization Required? |
|---|---|---|
| Ozempic (diabetes) | Covered by most provincial plans and private insurers | Usually no for diabetes; yes if off-label |
| Wegovy | Limited — private plans inconsistent; provincial plans rarely cover | Typically yes |
| Rybelsus | Most provincial plans and private insurers for diabetes | Occasionally |
| Compounded | Rarely covered by any plan | N/A |
Coverage rules change frequently. Check your specific plan and consult the formulary for Ontario, British Columbia, Alberta, Quebec or your province before assuming coverage.
Medical Expense Tax Credit
Out-of-pocket costs for any of these semaglutide products count as eligible medical expenses for the federal Medical Expense Tax Credit (METC). For the 2026 tax year, the threshold is the lesser of $2,834 or 3% of net income. Receipts from pharmacy dispenses count; save them year-round [7].
Online Providers Cost Comparison
Canadian telehealth providers bundle consultation, prescription and (in some cases) medication delivery into a single workflow. The monthly prices below reflect total out-of-pocket cost for semaglutide-based programs; specific product (Ozempic vs. Wegovy vs. compounded) varies by provider.
Top pick: MyRocky (operated by Rocky Health Inc.) is our highest-rated Canadian GLP-1 provider in 2026 (9.4/10). Per-pen pricing is roughly comparable across the major Canadian telehealth services - what MyRocky wins on is total value: the $99 one-time consult includes lab work and the first prescription, there are no recurring quarterly fees, free fast delivery is included, and it operates its own LegitScript-certified pharmacy in Mississauga. MyRocky also serves all 10 provinces (Felix and Hims do not operate in Quebec) and has been trusted by 350,000+ Canadians. Visit MyRocky or read our full MyRocky review.
| Provider | Monthly Program Cost | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| MyRocky ⭐ Top Pick | $300–$310 | $99 once (lab work included) | All 10 provinces | Visit MyRocky |
| Felix Health | Brand $250–$310 / Generic $149 | $99 setup + $40 quarterly | All provinces except QC | Visit Felix |
| Maple | $270–$320 | $69 per consult | All provinces | Visit Maple |
| Hims Canada | Generic $149 all-in | Included | Select provinces | Visit Hims |
| Jill Health | Pricing on assessment | Included in program | Most provinces | Visit Jill |
| DooU | Pricing on assessment | Included in program | Most provinces | Visit DooU |
| Raven | Pricing on assessment | Included in program | Most provinces | Visit Raven |
Provider reviews: MyRocky (top pick), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.
Clinical Effectiveness and Side Effects
All four options share the same active molecule, so the safety profile is broadly similar. Effectiveness depends mostly on dose: higher doses (Wegovy 2.4 mg) produce more weight loss, lower doses (Rybelsus 14 mg oral) produce less. The table below summarizes the pivotal trial results for each product.
| Product (Dose) | Pivotal Trial | Primary Outcome | Weight Change | A1C Change | Duration |
|---|---|---|---|---|---|
| Ozempic (1.0 mg) | SUSTAIN 7 | A1C in T2D | -4.6 kg | -1.5% | 40 weeks |
| Ozempic (2.0 mg) | SUSTAIN FORTE | A1C in T2D | -6.9 kg | -2.1% | 40 weeks |
| Wegovy (2.4 mg) | STEP 1 | Weight in BMI ≥ 30 | -14.9% body weight | N/A (non-diabetic population) | 68 weeks |
| Wegovy (2.4 mg) | SELECT | Cardiovascular outcomes | -9.4% body weight | N/A | 174 weeks (mean) |
| Rybelsus (14 mg) | PIONEER 1 | A1C in T2D | -3.7 kg | -1.5% | 26 weeks |
STEP 1 is the standout — nearly 15% average body weight reduction over 68 weeks changed the way Canadian clinicians think about obesity pharmacotherapy [4]. SELECT added cardiovascular benefit to the picture. For patients who need A1C control without injections, Rybelsus delivers meaningful reductions without the needle.
Side Effect Comparison
Side effects are primarily gastrointestinal and are dose-dependent. Wegovy’s higher maximum dose drives the higher rates seen below. Most patients experience the worst symptoms during dose escalation; they usually subside at steady-state dosing [8].
| Side Effect | Ozempic | Wegovy | Rybelsus | Compounded |
|---|---|---|---|---|
| Nausea | 15–20% | 20–44% | 11–20% | Reported, no standardized data |
| Vomiting | 5–9% | 6–25% | 5–8% | Reported, no standardized data |
| Diarrhea | 8–12% | 10–30% | 8–12% | Reported, no standardized data |
| Constipation | 5–8% | 10–24% | 4–7% | Reported, no standardized data |
| Injection site reactions | 0.2–1% | 0.2–1% | N/A (oral) | Variable |
| Pancreatitis (rare) | <1% | <1% | <1% | Unknown frequency |
| Gallbladder events | 1–2% | 1.5–3% | <1% | Unknown frequency |
Compounded semaglutide lacks the rigorous post-market surveillance data that Novo Nordisk products have. Adverse events are reported anecdotally, but we do not have standardized denominators or independent audits of compounded preparations [9].
Which Semaglutide Is Best for Your Situation?
There is no single “best” semaglutide. The right choice depends on why you are taking it, what insurance covers and how you tolerate titration. The table below maps common scenarios to the product most Canadians in that situation end up on.
| Your Situation | Best Option | Why |
|---|---|---|
| Type 2 diabetes, private insurance | Ozempic | Widely covered, strong A1C reduction, proven cardiovascular benefit |
| Type 2 diabetes, prefer no injections | Rybelsus | Only oral semaglutide; solid A1C control |
| Weight management, insurance covers Wegovy | Wegovy | Health Canada-approved; highest dose; strongest weight-loss data |
| Weight management, no coverage | Generic semaglutide or Ozempic off-label | Generic is lowest cost (about $88/mo at Costco); off-label Ozempic uses a covered formulary |
| Both diabetes and weight goals | Ozempic 2.0 mg | Covers both indications; best insurance pathway |
| Budget is the top priority | Generic semaglutide (~$88/mo at Costco) | Lowest monthly cost, bioequivalent to Ozempic |
| Want the most clinical data | Wegovy 2.4 mg | STEP program plus SELECT trial |
One honest note on compounded semaglutide: it fills a gap for Canadians who could not afford brand-name products, but it does not carry the same evidentiary backing. Now that generic semaglutide has launched at roughly $88 per month at Costco, cost is rarely a reason to choose a compounded formulation over the Health Canada-approved generic. See our generic semaglutide guide.
Generic Semaglutide Is Now Available in Canada
Novo Nordisk's Canadian exclusivity on semaglutide lapsed on January 4, 2026. Health Canada has since approved two generics: Dr. Reddy's Laboratories on April 28, 2026, which made Canada the first G7 country to clear a generic, and Apotex's Apo-Semaglutide Injection on May 1, 2026, the first Canadian-made version. Seven more submissions are still under review [10].
Since the May 2026 launch, cash retail prices have come in well below the telehealth alternatives, based on early Canadian consumer reports. Costco Pharmacy is the cheapest reliable option at roughly $88 to $99 per month, Walmart and No Frills run about $95 to $110, and Shoppers Drug Mart, Rexall and London Drugs sit around $100 to $120, about one-third the price of brand Ozempic. The wholesale numbers explain the gap: per the Globe and Mail, Apotex lists a $78.14 wholesale price for a four-week supply versus $240.48 for brand Ozempic. Telehealth providers Felix and Hims both charge $149 per month all-in for the same Apo-Semaglutide pen.
Health Canada has confirmed that the approved generics are bioequivalent to brand Ozempic: the same active ingredient at the same dose, in the same 0.25 to 2 mg pens. They are approved for type 2 diabetes, not Wegovy's 2.4 mg weight-management dose, but off-label prescribing for weight loss is common. For the full picture, see our generic semaglutide in Canada page.
FAQ
Is Ozempic or Wegovy better for weight loss?
For Canadians who have insurance coverage for Wegovy, Wegovy is the stronger choice — it is Health Canada-approved for weight management and reaches a higher maximum dose (2.4 mg vs. 2.0 mg). STEP 1 showed roughly 15% average body weight reduction on Wegovy. Ozempic off-label use produces less weight loss but is more widely covered.
Is Rybelsus as effective as injectable semaglutide?
Rybelsus delivers meaningful A1C reductions (around 1.5% on the 14 mg dose in PIONEER 1) and modest weight loss, but injectable semaglutide at higher doses produces larger effects. Rybelsus is a good fit for patients who need oral convenience and have well-managed diabetes.
Is compounded semaglutide safe?
Compounded semaglutide from a licensed Canadian compounding pharmacy is prepared to pharmacy-grade standards, but it does not go through the same Health Canada approval or post-market surveillance as Ozempic, Wegovy or Rybelsus. Quality varies between pharmacies. With generic semaglutide now available in Canada (Dr. Reddy's and Apotex), it will offer a lower-cost option with the regulatory backing that compounded versions lack.
Can I switch between Ozempic, Wegovy and Rybelsus?
Yes, with a prescriber. Patients commonly switch between these products as insurance coverage, tolerability or goals change. Switching between injectables is relatively simple; switching from injectable to oral (or vice versa) may require a short re-titration to avoid GI side effects.
How much will generic semaglutide cost in Canada?
Since the May 2026 launch, cash pharmacy prices run roughly $88 to $99 per month at Costco, the cheapest option, and about $100 to $120 at chain pharmacies like Shoppers and Rexall. That is roughly one-third the cost of brand Ozempic.
Which semaglutide does private insurance cover?
Ozempic is the most consistently covered for type 2 diabetes. Rybelsus is also well-covered for diabetes. Wegovy coverage for weight management varies significantly between plans and typically requires prior authorization. Compounded semaglutide is rarely covered.
Do I need a prescription for any of these?
Yes. Ozempic, Wegovy, Rybelsus and compounded semaglutide all require a prescription from a licensed Canadian prescriber. Telehealth providers like Felix, Maple and Hims Canada can issue prescriptions online after a clinical assessment.
Sources
- Health Canada — Drug Product Database: Semaglutide: Official listing of approved semaglutide products in Canada.
- SELECT Trial — Semaglutide and Cardiovascular Outcomes (NEJM, 2023): 20% reduction in major adverse cardiovascular events with Wegovy in overweight/obesity.
- SUSTAIN 6 — Cardiovascular Outcomes in Patients with Type 2 Diabetes (NEJM): Cardiovascular safety and benefit data for Ozempic in T2D.
- STEP 1 — Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021): Pivotal weight-loss trial for Wegovy 2.4 mg.
- Novo Nordisk Canada — Wegovy Product Monograph: Official Canadian product information and pricing references for Wegovy.
- PIONEER 1 — Oral Semaglutide in Type 2 Diabetes (Diabetes Care): Pivotal A1C and weight data for Rybelsus 14 mg.
- Canada Revenue Agency — Medical Expense Tax Credit: 2026 tax-year METC threshold and eligible medical expenses.
- Health Canada — Adverse Reaction Reporting (Canada Vigilance): Post-market surveillance program for approved drugs.
- NAPRA — National Association of Pharmacy Regulatory Authorities: Compounding Standards: Canadian standards for pharmacy compounding.
- Patented Medicine Prices Review Board — Generic Drug Pipeline (2026): Industry reporting on generic semaglutide submissions under review.